Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP523064.RADkSDreKbzbiPvFjdB1oZdjN3NV21RlrehdvQODJzpAM130_assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523064.RADkSDreKbzbiPvFjdB1oZdjN3NV21RlrehdvQODJzpAM130_provenance.
• NP1134427.RAD1YHwtLjPEbapFZzxnYXxsoNe0E7eQabR4f_7OIvenQ130_assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134427.RAD1YHwtLjPEbapFZzxnYXxsoNe0E7eQabR4f_7OIvenQ130_provenance.
• NP987570.RATyKTQocLbD3GXUJZLBqA3kKKxiGqQcELQbYjD9yaBTE130_assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP987570.RATyKTQocLbD3GXUJZLBqA3kKKxiGqQcELQbYjD9yaBTE130_provenance.
• NP873545.RA6Z-04tLfYdEXP1lrH7gc3htRQwgBcLbDz1yST4cVEdw130_assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873545.RA6Z-04tLfYdEXP1lrH7gc3htRQwgBcLbDz1yST4cVEdw130_provenance.
• NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
• assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1134428.RAKnOP8DEPD_f6WMN1fK0swJv0pYdQdKJdFfAT7Z5XtIU130_assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134428.RAKnOP8DEPD_f6WMN1fK0swJv0pYdQdKJdFfAT7Z5XtIU130_provenance.
• assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1014012.RAg_WoTfUA0WWC8TkLu366FkEik7GMIcUauG4Bm4xPRdE130_assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014012.RAg_WoTfUA0WWC8TkLu366FkEik7GMIcUauG4Bm4xPRdE130_provenance.
• NP900575.RAquI2ciHQIxBghw2JxAh4cXMPBNjZhIy6iaYBYnl8TUs130_assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900575.RAquI2ciHQIxBghw2JxAh4cXMPBNjZhIy6iaYBYnl8TUs130_provenance.
• NP1134426.RAn3PRw7Moym0X4Pr1CvzN5oFVqy1LA_KWleTIhT48XOw130_assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134426.RAn3PRw7Moym0X4Pr1CvzN5oFVqy1LA_KWleTIhT48XOw130_provenance.